
/
In recent years, with the improvement of China's economic level and the rise of female consciousness, women's health has been receiving increasing attention. Whether at the individual or societal level, women's health has been elevated to a higher level of concern.
According to statistics from the consulting firm Frost & Sullivan, the market size of women’s health management platforms grew from RMB 510 million in 2013 to RMB 13.0 billion in 2018, representing a compound annual growth rate (CAGR) of 91.3%, and is projected to reach RMB 47.17 billion by 2024. Meanwhile, the state has issued a series of policies. The Outline of the “Healthy China 2030” Plan emphasizes “health for all,” prioritizing prevention, strengthening early diagnosis, early treatment, and early rehabilitation, and carrying out early screening and treatment for major cancers in high-incidence areas. The Healthy China Action (2019–2022) states that by 2022, the coverage rate of county-level districts offering “two-cancer” screening for eligible rural women should reach 80%.
Driven by broad development prospects and strong policy support, the female health management market has given rise to numerous successful enterprises in this sector. Women are increasingly taking charge of their own physical well-being, while also making more personalized choices in selecting, purchasing, and accessing a diverse array of healthcare products and services.
In this context,VB100, VCBeat, and FemTec HealthCo-hosting the Women's Health Innovation ForumTo continuously drive innovative development in the women's health industry and conduct in-depth discussions on full-lifecycle management of women's health and global trends in women's health development, this forum brings together renowned experts, leading enterprises, and capital investors. It interprets the development of women's health from perspectives including forward-looking vision, scenario-based applications, and innovation ecosystems, fostering pioneering dialogues that are forward-thinking, authoritative, and predictive.


Forum Dates: Late May to Early June 2022, Day 2
Venue: Shishan International Conference Center, Suzhou, Jiangsu
Forum Organizers: VB100, VCBeat, Arterial Orange, Eggshell Research Institute
Co-organized by: FemTec Health
● 14:00-14:20
The Development of the Women's Health Industry from an International Research Perspective
FemTec Health CEO
● 14:20-14:40
Analysis of the Development Prospects of the Global Women's Health Industry: Practices and Reflections from FemTec Health
Bu Qihong | Chief Operating Officer, FemTec Health Asia
● 15:00-15:20
Analysis of Contemporary Women's Health Needs and Trends
Relevant Executives from Domestic and International Enterprises in Related Fields
● 15:20-15:40
AI-Powered Precision Screening for Breast Cancer
Shi Jing | Product Director, United Imaging Intelligence
● 15:40-16:00
Exploring New Models for Endometrial Cancer Screening
Liu Pei | CEO of Juhe Biotech
● 16:00-16:20
Reflections and Explorations on Female Endocrine Testing and Management in the Era of At-Home Testing
Wang Qiangyu | Founder and CEO of Yisheng Jiankang
● 16:20-16:40
The Digital "Code" Behind the Hundred-Million-Yuan Revenue of Postpartum Health Management Services for Women
Zhu Xiaoxiao | Founder and CEO of FitTime
● 16:40-17:20
Expert Roundtable: One-Stop Management Ecosystem for Women’s Health—What Are the Innovative Models for the Future?
● 17:20-18:00
Roundtable with Industry Leaders: International · Innovation · Collaboration — New Approaches to Expanding the Women’s Health Market
Section 1: Forward-Looking Perspective
Speaker: CEO of FemTec Health
Title: Development of the Women's Health Industry from an International Research Perspective
The women’s health industry represents a market opportunity that cannot be missed. A comprehensive understanding of this sector cannot be achieved by focusing solely on the domestic market. To more accurately grasp the development of this industry, international scientific research has become an indispensable step.
Speakers:Bu Qihong |FemTec Health Chief Operating Officer, Asia
Title: Analysis of the Development Prospects of the Global Women's Health Industry: Femtec Health's Practices and Reflections
The women’s health industry is garnering increasing attention, with a growing number of companies preparing to enter this market. As the sector emerges, analyzing its development prospects becomes essential. FemTec Health, as a personalized, full-lifecycle women’s health management and service platform, provides comprehensive, tailored health services and products by building a women’s health database and intelligent predictive models. An analysis of this company helps clarify the industry’s growth potential and supports its further development.
Section 2: Scenario Applications
Proposed Invitees: Relevant Executives from Domestic and International Companies in Related Fields
Proposed Title: Analysis of Contemporary Women's Health Needs and Trends
For a company to enter a market, it must have a clear understanding of that market. To enter the women's health industry, companies should precisely focus on women's health needs and future development trends, directly address the "pain points" in the women's health sector, and ensure stable market entry.
Speaker: Shi Jing | Product Director, United Imaging Intelligence
Title: AI-Driven Precision Screening for Breast Cancer
Precision screening is the most critical approach to improving breast cancer cure rates; therefore, the application of artificial intelligence in breast cancer screening can serve as a valuable aid. Let us examine how United Imaging Intelligence is strategizing in this domain.
Speaker: Liu Pei | CEO of Juhe Biology
Title: Exploring New Models for Endometrial Cancer Screening
As the most common gynecological malignancy, endometrial cancer poses a significant threat to women's health, making screening particularly crucial in safeguarding their well-being. It is essential to explore novel screening models for endometrial cancer, strengthen preventive measures, and achieve early detection and treatment to protect women's health.
Speaker: Wang Qiangyu | Founder and CEO of Yisheng Jiankang
Proposed Title: Reflections and Explorations on Female Endocrine Testing and Management in the Era of At-Home Testing
With an increasing number of test kits available for home use, how should female endocrine testing and management be conducted in the realm of women’s health amid the surge in at-home testing? What lies ahead for this field?
Speaker: Zhu Xiaoxiao | Founder and CEO of FitTime
Title: The Digital "Code" Behind the Hundred-Million-Yuan Revenue of Postpartum Health Management Services for Women
Nowadays, women are paying more attention to their health management, and this is also true for postpartum women. Data shows that the revenue from postpartum health management services has reached hundreds of millions. What factors contribute to such high revenue in this field?
Section 3: Innovation Ecosystem
Roundtable Topic: One-Stop Management Ecosystem for Women's Health: What Are the Innovative Models for the Future?
The female health industry is developing from multiple perspectives, collectively serving women's health. In the face of one-stop management for women's health, more innovative models will emerge in the future.
Proposed Roundtable Topic: International · Innovation · Cooperation — New Approaches to Expanding the Women’s Health Market
1. Lessons from Abroad: What Can Chinese Enterprises Learn from International Experience as They Expand Overseas?2. What Opportunities and Challenges Do Domestic Policies Present for the International Development of Women’s Health Enterprises?3. Building a New Ecosystem: How Can Domestic and International Enterprises Collaborate to Accelerate the Rapid Development of the Women’s Health Industry?
● Mapping the Industry Landscape, Telling China’s Story: The 2022 Top 100 Future Healthcare Companies Conference Held with Great Momentum
From “Eye of the Storm,” “Species Big Bang,” “Tide Direction ING,” and “New Growth in Life” to “The Calculation of Life”; from 20 guests, 150 companies, and 400 attendees at the inaugural event to a cumulative total of over 1,000 domestic and international speakers, more than 5,000 participating enterprises, over 20,000 attendee visits, and 5 million+ impressions... The Future Healthcare Top 100 Conference has grown alongside China’s medical and health industry, continuously expanding to become the largest and most information-rich summit integrating industry and capital within China’s healthcare innovation sector.
The 6th Future Healthcare Top 100 Conference will be held at the Shishan International Conference Center in Suzhou, Jiangsu Province. This year, we will collaborate with embassies from various countries to jointly host roadshows for global healthcare innovation projects. Embarking with a renewed vision, we will focus on “China’s Story,” ground ourselves in innovation, and faithfully document the trajectory of the global healthcare industry. We will identify leading innovative enterprises in the sector and analyze industry hotspots from five dimensions: policy orientation, technological frontiers, capital perspectives, industrial innovation, and market demand. By interpreting development trends in the future healthcare industry, we aim to drive transformative change in the innovative healthcare sector. Our goal is to converge core industry forces, promote transformation in the innovative healthcare industry, and build a comprehensive exchange and matchmaking platform for the entire medical and health industry chain.
● Convergence of Multiple Highlights Creates a Premier 2022 Healthcare Industry Event in China
# Top-Tier Guest Lineup——Led by Academician Scientists300+ Key Opinion LeadersDelivering Three Days of Cutting-Edge Medical Technology, Industry Trends, and Business Innovation
Business Wisdom of Industry Leaders——ChinaStrategic Launch by Benchmark Listed Companies, Insights into the Future of the Industry and the Innovation Landscape
Global Perspective and Overseas Resources——FromThe United Kingdom, Canada, Belgiumand the industrial development trends and capital markets of multiple countries, linking high-quality overseas technological innovation projects
In-Depth Insights into Niche Segments——Major AnnouncementSix Industry Research Series Reports, Exploring Development Opportunities and Innovative Cases in Niche Fields
Gathering the Core Forces of Future Healthcare—— ReleaseFive Top 100 Lists and Two Awards, bringing together 1,000+ unicorns and high-potential innovative enterprises to jointly explore pathways for innovative development
A Forward-Looking Capital Perspective——100+ including GP/LP/CVC/VC/PE/FA, etc.Financial Institutions as Forward-Looking Investors: Sensing the Direction of Capital Heat in the Industry
/

Conference Dates: Late May or Early June 2022
Venue: Shishan International Conference Center, Suzhou, China
Limited-Time Offer: Conference All-Access Pass
Purchase Channels:Search for the “VB100” mini-program on WeChat to purchase.
Two types of general admission passes are available for public sale at this conference:
RMB 899 [VB100 All-Access Pass, Meals Not Included]RMB 1,299 [VB100 All-Access Pass with Meals],Limited-Time Offer · Conference All-Access PassSave ¥630 off the original price, now as low as ¥269Onset:
Your trust will entitle you to the following benefits:
1. All-Access Pass for Forum, Exhibition, and Interactive Events (Separate registration required for certain segments such as LPGP)
2. On-Site Resource Coordination and Communication Group
3. Authorized materials by guests, including PPTs, conference proceedings, and public reports
4. Lunch vouchers during the conference (only for those with meal tickets)
Special Note:
1. Duration of This Limited-Time OfferUpdates on Key Milestones from Today Until the Next Meeting;
2. Ticket prices will be adjusted as information regarding the conference theme, speakers, topics, and exhibitors is unveiled,Increase by 100 yuan each time until the original price is restored;
3、After this limited-time offer ends,Ticket prices will rise to 369 yuan.Onset

Scan the QR code to register for the 2022 · 6th Future Healthcare Top 100 Conference

Consultation for the 2022 Future Healthcare Top 100 Conference

